Startups Stand Out As 13 Biotechs Raise More Than $409m

Venture capital and other private equity investment is booming with 13 recent drug developer financings totaling more than $409m, including 10 startups with some large Series A rounds, showing that the biotechnology industry remains attractive to investors even if the window is closing for initial public offerings in the US.